These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15809504)

  • 21. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocompatibility aspects of dialyzer reprocessing: a comparison of 3 re-use methods and 3 membranes.
    Kuwahara T; Markert M; Wauters JP
    Clin Nephrol; 1989 Sep; 32(3):139-43. PubMed ID: 2791365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
    Starzyk J; Bartelik S; Sarnecka S
    Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report.
    Post JB
    Am J Kidney Dis; 2010 Jun; 55(6):e25-8. PubMed ID: 20110145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction.
    Schaefer RM; Rauterberg EW; Deppisch R; Vienken J
    Miner Electrolyte Metab; 1990; 16(1):73-6. PubMed ID: 2325595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein catabolism in sham-hemodialysis: the effect of different membranes.
    Gutierrez A; Bergström J; Alvestrand A
    Clin Nephrol; 1992 Jul; 38(1):20-9. PubMed ID: 1499165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research on dialyzers with improved biocompatibility.
    van der Steen A
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition.
    Kiykim AA; Horoz M; Ozcan T; Yildiz I; Sari S; Genctoy G
    Ren Fail; 2010; 32(10):1148-52. PubMed ID: 20954973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin E-bonded cellulose membrane and hemodialysis bioincompatibility: absence of an acute benefit on expression of leukocyte surface molecules.
    Dhondt A; Vanholder R; Glorieux G; Waterloos MA; De Smet R; Lesaffer G; Lameire N
    Am J Kidney Dis; 2000 Dec; 36(6):1140-6. PubMed ID: 11096038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocompatibility parameters of different dialysis membranes assessed during systemic inflammation.
    Gueler F; Gwinner W; Schiborr C; Martin M; Klos A; Kirsch T; Fiebeler A; Haller H; Fliser D
    Blood Purif; 2005; 23(3):196-202. PubMed ID: 15711040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
    Orłowski A; Szepietowski T
    Polim Med; 1992; 22(1-2):59-72. PubMed ID: 1461837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fundamental Characteristics of the Newly Developed ATA™ Membrane Dialyzer.
    Sunohara T; Masuda T
    Contrib Nephrol; 2017; 189():215-221. PubMed ID: 27951571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: a prospective randomised multicentre trial. International Multicentre Study Group.
    Jörres A; Gahl GM; Dobis C; Polenakovic MH; Cakalaroski K; Rutkowski B; Kisielnicka E; Krieter DH; Rumpf KW; Guenther C; Gaus W; Hoegel J
    Lancet; 1999 Oct; 354(9187):1337-41. PubMed ID: 10533862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of hemodialysis membrane and permeability on neutrophil transmigration in vitro.
    Moshfegh A; Jacobson SH; Halldén G; Thylén P; Lundahl J
    Nephron; 2002 Aug; 91(4):659-65. PubMed ID: 12138270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations.
    Pieroni L; Levi Mortera S; Greco V; Sirolli V; Ronci M; Felaco P; Fucci G; De Fulviis S; Massoud R; Condò S; Capria A; Di Daniele N; Bernardini S; Urbani A; Bonomini M
    Mol Biosyst; 2015 Jun; 11(6):1633-43. PubMed ID: 25845767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein catabolism in maintenance haemodialysis: the influence of the dialysis membrane.
    Gutierrez A
    Nephrol Dial Transplant; 1996; 11 Suppl 2():108-11. PubMed ID: 8804008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a new cellulose triacetate membrane with a microgradient porous structure for hemodialysis.
    Akizawa T; Kinugasa E; Sato Y; Kohjiro S; Naitoh H; Azuma M; Mizutani S; Ideura T
    ASAIO J; 1998; 44(5):M584-6. PubMed ID: 9804500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial dialysis membranes: from concept to large scale production.
    Vienken J; Diamantoglou M; Henne W; Nederlof B
    Am J Nephrol; 1999; 19(2):355-62. PubMed ID: 10213843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection guidelines for high-performance membrane.
    Sanaka T; Koremoto M
    Contrib Nephrol; 2011; 173():30-35. PubMed ID: 21865773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.